The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor
- 1 May 1984
- journal article
- research article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 35 (2-3), 89-96
- https://doi.org/10.1016/0303-7207(84)90004-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- The biology and physiology of ‘Nolvadex’ (tamoxifen) in the treatment of breast cancerBreast Cancer Research and Treatment, 1982
- Differences between oestrogen receptor activation by oestrogen and antioestrogenNature, 1981
- High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metaboliteMolecular and Cellular Endocrinology, 1980
- A secreted glycoprotein induced by estrogen in human breast cancer cell linesCell, 1980
- Antiestrogen specific, high affinity saturable binding sites in rat uterine cytosolBiochemical and Biophysical Research Communications, 1980
- Differential binding of antiestrogens by rat uterine and chick oviduct cytosolBiochemical and Biophysical Research Communications, 1979
- Epithelioid and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformationJournal of Cellular Physiology, 1978
- Binding properties of an anti-estrogen to the estradiol receptor of uterine cytosolFEBS Letters, 1972
- The Use of Estrogen Antagonists in Hormone Receptor StudiesGynecologic and Obstetric Investigation, 1972